Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00216632
What this trial is testing

Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 99
Post-approval studies (Phase 4)Study completedNCT00237861
What this trial is testing

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Who this might be right for
Schizophrenia
Yale University
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Not applicableEnded earlyNCT02020356
What this trial is testing

Music Therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
University Hospital, Toulouse 35
Not applicableStudy completedNCT05473741
What this trial is testing

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Who this might be right for
SchizophreniaSchizophrenia Relapse
Centre for Addiction and Mental Health 51
Post-approval studies (Phase 4)Study completedNCT01157351
What this trial is testing

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 450
Early research (Phase 1)Study completedNCT00791167
What this trial is testing

The Dose Proportionality of Extended Release Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 58
Post-approval studies (Phase 4)Ended earlyNCT01592201
What this trial is testing

A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 13
Early research (Phase 1)Ended earlyNCT00272025
What this trial is testing

Treatment Resistant Bipolar Depression

Who this might be right for
Bipolar Depression
Queen's University 1
Testing effectiveness (Phase 2)Study completedNCT01852331
What this trial is testing

Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizophrenic DisorderHyperprolactinemia+1 more
The University of Hong Kong 103
Post-approval studies (Phase 4)Ended earlyNCT05741502
What this trial is testing

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Who this might be right for
Treatment-resistant Schizophrenia
Ohio State University 5
Testing effectiveness (Phase 2)Study completedNCT02281773
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

Who this might be right for
Schizophrenia
Boehringer Ingelheim 518
Not applicableStudy completedNCT00689325
What this trial is testing

Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

Who this might be right for
Schizophrenia
AstraZeneca 158
Not applicableUnknownNCT00698295
What this trial is testing

Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication

Who this might be right for
Schizophrenia
Seoul National University Hospital 60
Large-scale testing (Phase 3)Study completedNCT00086112
What this trial is testing

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Who this might be right for
Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 301
Not applicableEnded earlyNCT01867398
What this trial is testing

Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders

Who this might be right for
Conduct DisorderfMRI
National Institute of Mental Health (NIMH) 12
Large-scale testing (Phase 3)Study completedNCT03510325
What this trial is testing

Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 762
Not applicableUnknownNCT02137616
What this trial is testing

Antipsychotic to Treat Psychosis Syndrome

Who this might be right for
Psychotic Disorders
Central South University 300
Not applicableStudy completedNCT00480168
What this trial is testing

A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics

Who this might be right for
Adverse Effects
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50
Post-approval studies (Phase 4)Study completedNCT01726335
What this trial is testing

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 53
Next Page